Title:
COMPOSITION COMPRISING PI3 KINASE INHIBITOR AND BTK INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2021/182903
Kind Code:
A1
Abstract:
The present invention provides a composition comprising: a compound represented by chemical formula 1, an isomer thereof, or a pharmaceutically acceptable salt thereof; and a BTK inhibitor. The composition of the present invention exhibits an excellent lymphatic tumor treatment effect.
Inventors:
LEE JOO HAN (KR)
WANG SEUNGHO (KR)
YANG EUNHEE (KR)
PARK MIN (KR)
JEON BYEONGWOOK (KR)
LEE BO RAM (KR)
SON MIKWON (KR)
KIM SOO JUNG (KR)
WANG SEUNGHO (KR)
YANG EUNHEE (KR)
PARK MIN (KR)
JEON BYEONGWOOK (KR)
LEE BO RAM (KR)
SON MIKWON (KR)
KIM SOO JUNG (KR)
Application Number:
PCT/KR2021/003058
Publication Date:
September 16, 2021
Filing Date:
March 11, 2021
Export Citation:
Assignee:
BORYUNG PHARM (KR)
International Classes:
A61K31/519; A61K45/06; A61P35/02
Domestic Patent References:
| WO2019183226A1 | 2019-09-26 | |||
| WO2016209961A1 | 2016-12-29 |
Foreign References:
| KR20160150006A | 2016-12-28 | |||
| KR20160093062A | 2016-08-05 | |||
| KR20170074381A | 2017-06-30 |
Attorney, Agent or Firm:
AHN, So Young (KR)
Download PDF: